[Aroor AR, McKarns S, Demarco VG, Jia G, Sowers JR. Maladaptive immune and inflammatory pathways lead to cardiovascular insulin resistance. Metabolism 62, 1543–1552, 2013.10.1016/j.metabol.2013.07.001380933223932846]Search in Google Scholar
[Brestoff JR, Artis D. Immune regulation of metabolic homeostasis in health and disease. Cell 161, 146–160, 2015.10.1016/j.cell.2015.02.022440028725815992]Search in Google Scholar
[Brie D, Sahebkar A, Penson PE, Dinca M, Ursoniu S, Serban MC, Zanchetti A, Howard G, Ahmed A, Aronow WS, Muntner P, Lip GY, Wong ND, Rysz J, Banach M. Effects of pentoxifylline on inflammatory markers and blood pressure: a systematic review and meta-analysis of randomized controlled trials. J Hypertens 34, 2318–2329, 2016.10.1097/HJH.000000000000108627512972]Search in Google Scholar
[Catoi AF, Parvu A, Mureşan A, Busetto L. Metabolic mechanisms in obesity and type 2 diabetes: Insights from bariatric/metabolic surgery. Obes Facts 8, 350–363, 2015.10.1159/000441259564481326584027]Search in Google Scholar
[Chang CH, Curtis JD, Maggi LB Jr, Faubert B, Villarino AV, O’Sullivan D, Huang SC, van der Windt GJ, Blagih J, Qiu J, Weber JD, Pearce EJ, Jones RG, Pearce EL. Posttranscriptional control of T cell effector function by aerobic glycolysis. Cell 153, 1239–1251, 2013.10.1016/j.cell.2013.05.016380431123746840]Search in Google Scholar
[Chen YM, Chiang WC, Lin SL, Tsai TJ. Therapeutic efficacy of pentoxifylline on proteinuria and renal progression: an update. J Biomed Sci 24, 84, 2017.10.1186/s12929-017-0390-4568355629132351]Search in Google Scholar
[Clavel T, Haller D. Bacteria- and host-derived mechanisms to control intestinal epithelial cell homeostasis: implications for chronic inflammation. Inflamm Bowel Dis 13, 1153–1164, 2007.10.1002/ibd.2017417476679]Search in Google Scholar
[Clavel T, Desmarchelier C, Haller D, Gerard P, Rohn S, Lepage P, Daniel H. Intestinal microbiota in metabolic diseases: from bacterial community structure and functions to species of pathophysiological relevance. Gut Microbes 5, 544–551, 2014.10.4161/gmic.2933125003516]Search in Google Scholar
[Dai Y, Dai D, Wang X, Ding Z, Mehta JL. DPP-4 inhibitors repress NLRP3 inflammasome and interleukin-1beta via GLP-1 receptor in macrophages through protein kinase C pathway. Cardiovasc Drugs Ther 28, 425–432, 2014.10.1007/s10557-014-6539-425022544]Search in Google Scholar
[de Laat MA, McGree JM, Sillence MN. Equine hyperinsulinemia: investigation of the enteroinsular axis during insulin dysregulation. Am J Physiol Endocrinol Metab 310, E61–E72, 2016.10.1152/ajpendo.00362.201526530154]Search in Google Scholar
[Drucker DJ, Nauck MA. The incretin system: glucagon-like peptide-1 receptor agonists and dipeptidyl peptidase-4 inhibitors in type 2 diabetes. Lancet 368, 1696–1705, 2006.10.1016/S0140-6736(06)69705-5]Search in Google Scholar
[El-Sahar AE, Safar MM, Zaki HF, Attia AS, Ain-Shoka AA. Sitagliptin attenuates transient cerebral ischemia/reperfusion injury in diabetic rats: implication of the oxidative-inflammatory-apoptotic pathway. Life Sci 126, 81–68, 2015.10.1016/j.lfs.2015.01.03025721294]Search in Google Scholar
[Fasano A. Zonulin, regulation of tight junctions, and autoimmune diseases. Ann N Y Acad Sci 1258, 25–33, 2012.10.1111/j.1749-6632.2012.06538.x338470322731712]Search in Google Scholar
[Fisson S, Darrasse-Jeze G, Litvinova E, Septier F, Klatzmann D, Liblau R, Salomon BL. Continuous activation of autoreactive CD4+ CD25+ regulatory T cells in the steady state. J Exp Med 198, 737–746, 2003.10.1084/jem.20030686219418512939344]Search in Google Scholar
[Frauwirth KA, Thompson CB. Regulation of T lymphocyte metabolism. J Immunol 172, 4661–4665, 2004.10.4049/jimmunol.172.8.466115067038]Search in Google Scholar
[Garcia FA, Rebouças JF, Balbino TQ, da Silva TG, de Carvalho-Junior CH, Cerqueira GS, de Castro Brito GA, de Barros Viana GS. Pentoxifylline reduces the inflammatory process in diabetic rats: Relationship with decreases of pro-inflammatory cytokines and inducible nitric oxide synthase. J Inflamm (Lond) 12, 33, 2015.10.1186/s12950-015-0080-5441166025922592]Search in Google Scholar
[Gorboulev V, Schurmann A, Vallon V, Kipp H, Jaschke A, Klessen D, Friedrich A, Scherneck S, Rieg T, Cunard R, Veyhl-Wichmann M, Srinivasan A, Balen D, Breljak D, Rexhepaj R, Parker HE, Gribble FM, Reimann F, Lang F, Wiese S, Sabolic I, Sendtner M, Koepsell H. Na(+)-D-glucose cotransporter SGLT1 is pivotal for intestinal glucose absorption and glucose-dependent incretin secretion. Diabetes 61, 187–196, 2012.10.2337/db11-1029323764722124465]Search in Google Scholar
[Greiner TU, Backhed F. Microbial regulation of GLP-1 and L-cell biology. Mol Metab 5, 753–758, 2016.10.1016/j.molmet.2016.05.012500411727617198]Search in Google Scholar
[Guzyk MM, Dyakun KO, Yanytska LV, Pryvrotska IB, Krynytska IY, Pishel IM, Kuchmerovska TM. Inhibitors of poly(ADP-Ribose) polymerase-1 as agents providing correction of brain dysfunctions induced by experimental diabetes. Neurophysiology 49, 183–193, 2017.10.1007/s11062-017-9672-4]Search in Google Scholar
[Hadjiyanni I, Baggio LL, Poussier P, Drucker DJ. Exendin-4 modulates diabetes onset in nonobese diabetic mice. Endocrinology 149, 1338–1349, 2008.10.1210/en.2007-1137227536718063685]Search in Google Scholar
[Han SJ, Kim HJ, Kim DJ, Sheen SS, Chung CH, Ahn CW, Kim SH, Cho YW, Park SW, Kim SK, Kim CS, Kim KW, Lee KW. Effects of pentoxifylline on proteinuria and glucose control in patients with type 2 diabetes: a prospective randomized double-blind multicenter study. Diabetol Metab Syndr 7, 64, 2015.10.1186/s13098-015-0060-1]Search in Google Scholar
[Hogan AE, Tobin AM, Ahern T, Corrigan MA, Gaoatswe G, Jackson R, O’Reilly V, Lynch L, Doherty DG, Moynagh PN, Kirby B, O’Connell J, O’Shea D. Glucagon-like peptide-1 (GLP-1) and the regulation of human invariant natural killer T cells: lessons from obesity, diabetes and psoriasis. Diabetologia 54, 2745–2754, 2011.10.1007/s00125-011-2232-3]Search in Google Scholar
[Hosseini F, Mohammadbeigi A, Aghaali M, Borujerdi R, Parham M. Effect of pentoxifylline on diabetic distal polyneuropathy in type 2 diabetic patients: A randomized trial. J Res Med Sci 24, 89, 2019.10.4103/jrms.JRMS_115_18]Search in Google Scholar
[Khaleghi S, Ju JM, Lamba A, Murray JA. The potential utility of tight junction regulation in celiac disease: focus on larazotide acetate. Therap Adv Gastroenterol 9, 37–49, 2016.10.1177/1756283X15616576]Search in Google Scholar
[Klemann C, Wagner L, Stephan M, von Horsten S. Cut to the chase: a review of CD26/dipeptidyl peptidase-4’s (DPP4) entanglement in the immune system. Clin Exp Immunol 185, 1–21, 2016.10.1111/cei.12781]Search in Google Scholar
[Kooijman R, Coppens A, Hooghe-Peters EL. Insulin-like growth factor-I inhibits spontaneous apoptosis in human granulocytes. Endocrinology 143, 1206–1212, 2002.10.1210/endo.143.4.8725]Search in Google Scholar
[Kooijman R, Coppens A, Hooghe-Peters E. IGF-1 stimulates IL-8 production in the promyelocytic cell line HL-60 through activation of extracellular signal-regulated protein kinase. Cell Signal 15, 1091–1098, 2003.10.1016/S0898-6568(03)00069-X]Search in Google Scholar
[Kooijman R, Coppens A. Insulin-like growth facator-1 stimulates IL-10 production in human T cells. J Leukoc Biol 76, 862–867, 2004.10.1189/jlb.040424815277570]Search in Google Scholar
[Koval HD, Chopyak VV, Kamyshnyi OM, Kurpisz MK. Transcription regulatory factor expression in T-helper cell differentiation pathway in eutopic endometrial tissue samples of women with endometriosis associated with infertility. Cent Eur J Immunol 43, 90–96, 2018.10.5114/ceji.2018.74878592717829736151]Search in Google Scholar
[Krynytska І, Marushchak M. The indices of nitric oxide system in rats with carrageenan-induced enterocolitis combined with diabetes mellitus. Rom J Diabetes Nutr Metab Dis 25, 283–288, 2018.10.2478/rjdnmd-2018-0033]Search in Google Scholar
[Lamers D, Famulla S, Wronkowitz N, Hartwig S, Lehr S, Ouwens DM, Eckardt K, Kaufman JM, Ryden M, Muller S, Hanisch FG, Ruige J, Arner P, Sell H, Eckel J. The soluble form of DPP4 is characterized as adipokine Dipeptidyl peptidase 4 is a novel adipokine potentially linking obesity to the metabolic syndrome. Diabetes 60, 1917–1925, 2011.10.2337/db10-1707]Search in Google Scholar
[Lechleitner M, Koch T, Herold M, Dzien A, Hoppichler F. Tumour necrosis factor-alpha plasma level in patients with type 1 diabetes mellitus and its association with glycaemic control and cardiovascular risk factors. J Intern Med 248, 67–76, 2000.10.1046/j.1365-2796.2000.00705.x]Search in Google Scholar
[LeRoith D, Yakar S. Mechanisms of disease: metabolic effects of growth hormone and insulin-like growth factor 1. Nat Clin Pract Endocrinol Metab 3, 302–310, 2007.10.1038/ncpendmet0427]Search in Google Scholar
[Liu TY, Uemura Y, Suzuki M, Narita Y, Hirata S, Ohyama H, Ishihara O, Matsushita S. Distinct subsets of human invariant NKT cells differentially regulate T helper responses via dendritic cells. Eur J Immunol 38, 1012–1023, 2008.10.1002/eji.200737838]Search in Google Scholar
[Liu X, Linnington C, Webster HD, Lassmann S, Yao DL, Hudson LD, Wekerle H, Kreutzberg GW. Insulin-like growth factor-I treatment reduces immune cell responses in acute non-demyelinative experimental autoimmune encephalomyelitis. J Neurosci Res 47, 531–538, 1997.10.1002/(SICI)1097-4547(19970301)47:5<531::AID-JNR8>3.0.CO;2-I]Search in Google Scholar
[Michalek RD, Gerriets VA, Jacobs SR, Macintyre AN, MacIver NJ, Mason EF, Sullivan SA, Nichols AG, Rathmell JC. Cutting edge: distinct glycolytic and lipid oxidative metabolic programs are essential for effector and regulatory CD4+ T cell subsets. J Immunol 186, 3299–3303, 2011.10.4049/jimmunol.1003613]Search in Google Scholar
[Nguyen-Chi M, Laplace-Builhe B, Travnickova J, Luz-Crawford P, Tejedor G, Lutfalla G, Kissa K, Jorgensen C, Djouad F. TNF signaling and macrophages govern fin regeneration in zebrafish larvae. Cell Death Dis 8, e2979, 2017.10.1038/cddis.2017.374]Search in Google Scholar
[Ogata H, Seino Y, Harada N, Iida A, Suzuki K, Izumoto T, Ishikawa K, Uenishi E, Ozaki N, Hayashi Y, Miki T, Inagaki N, Tsunekawa S, Hamada Y, Seino S, Oiso Y. KATP channel as well as SGLT1 participates in GIP secretion in the diabetic state. J Endocrinol 222, 191–200, 2014.10.1530/JOE-14-0161]Search in Google Scholar
[Pearce EL. Metabolism in T cell activation and differentiation. Curr Opin Immunol 22, 314–320, 2010.10.1016/j.coi.2010.01.018]Search in Google Scholar
[Poppi L, Dixit VD, Baratta M, Giustina A, Tamanini C, Parvizi N. Growth hormone secretatogue (GHS) analogue, hexarelin stimulates GH from peripheral lymphocytes. Exp Clin Endocrinol Diabetes 110, 343–347, 2002.10.1055/s-2002-34991]Search in Google Scholar
[Powell DR, Smith M, Greer J, Harris A, Zhao S, DaCosta C, Mseeh F, Shadoan MK, Sands A, Zambrowicz B, Ding ZM. LX4211 increases serum glucagon-like peptide 1 and peptide YY levels by reducing sodium/glucose co-transporter 1 (SGLT1)-mediated absorption of intestinal glucose. J Pharmacol Exp Ther 345, 250–259, 2013.10.1124/jpet.113.20336423487174]Search in Google Scholar
[Putilin DA, Kamyshnyi AM. Сhanges of glut1, mtor and ampk1α gene expression in pancreatic lymph node lymphocytes of rats with experimental diabetes mellitus. Medical Immunology (Russia) 18, 339–346, 2016.10.15789/1563-0625-2016-4-339-346]Search in Google Scholar
[Qiao YC, Shen J, He L, Hong XZ, Tian F, Pan YH, Liang L, Zhang XX, Zhao HL. Changes of regulatory T cells and of proinflammatory and immunosuppressive cytokines in patients with type 2 diabetes mellitus: A systematic review and meta-analysis. J Diabetes Res 2016, 3694957, 2016.10.1155/2016/3694957506198027777959]Search in Google Scholar
[Qiao YC, Chen YL, Pan YH, Tian F, Xu Y, Zhang XX, Zhao HL. The change of serum tumor necrosis factor alpha in patients with type 1 diabetes mellitus: A systematic review and meta-analysis. PLoS One 12, e0176157, 2017.10.1371/journal.pone.0176157539863328426801]Search in Google Scholar
[Roder PV, Geillinger KE, Zietek TS, Thorens B, Koepsell H, Daniel H. The role of SGLT1 and GLUT2 in intestinal glucose transport and sensing. PLoS One 9, e89977, 2014.10.1371/journal.pone.0089977393595524587162]Search in Google Scholar
[Salgado FJ, Vela E, Martin M, Franco R, Nogueira M, Cordero OJ. Mechanisms of CD26/dipeptidyl peptidase IV cytokine-dependent regulation on human activated lymphocytes. Cytokine 12, 1136–1141, 2000.10.1006/cyto.1999.064310880264]Search in Google Scholar
[Sell H, Bluher M, Kloting N, Schlich R, Willems M, Ruppe F, Knoefel WT, Dietrich A, Fielding BA, Arner P, Frayn KN, Eckel J. Adipose dipeptidyl peptidase-4 and obesity: correlation with insulin resistance and depot-specific release from adipose tissue in vivo and in vitro. Diabetes Care 36, 4083–4090, 2013.10.2337/dc13-0496383615324130353]Search in Google Scholar
[Shi LZ, Wang R, Huang G, Vogel P, Neale G, Green DR, Chi H. HIF1alpha-dependent glycolytic pathway orchestrates a metabolic checkpoint for the differentiation of TH17 and Treg cells. J Exp Med 208, 1367–1376, 2011.10.1084/jem.20110278313537021708926]Search in Google Scholar
[Smith TJ. Insulin-like growth factor-I regulation of immune function: a potential therapeutic target in autoimmune diseases? Pharmacol Rev 62, 199–236, 2010.10.1124/pr.109.002469287991320392809]Search in Google Scholar
[Stentz FB, Kitabchi AE. Activated T lymphocytes in Type 2 diabetes: implications from in vitro studies. Curr Drug Targets 4, 493–503, 2003.10.2174/138945003349096612866664]Search in Google Scholar
[Topol IA, Kamyshny AM, Abramov AV, Kolesnik YM. Expression of XBP1 in lymphocytes of the small intestine in rats under chronic social stress and modulation of intestinal microflora composition. Fiziolohichnyi zhurnal 60, 38–44, 2014.10.15407/fz60.02.038]Search in Google Scholar
[Tu W, Cheung PT, Lau YL. Insulin-like growth factor 1 promotes cord blood T cell maturation and inhibits its spontaneous and phytohemagglutinin-induced apoptosis through different mechanisms. J Immunol 165, 1331–1336, 2000.10.4049/jimmunol.165.3.133110903734]Search in Google Scholar
[Wing JB, Tanaka A, Sakaguchi S. Human FOXP3+ regulatory T cell heterogeneity and function in autoimmunity and cancer. Immunity 50, 302–316, 2019.10.1016/j.immuni.2019.01.02030784578]Search in Google Scholar
[Wright EM, Loo DD, Hirayama BA. Biology of human sodium glucose transporters. Physiol Rev 91, 733–794, 2011.10.1152/physrev.00055.200921527736]Search in Google Scholar
[Wu J, Yan LJ. Streptozotocin-induced type 1 diabetes in rodents as a model for studying mitochondrial mechanisms of diabetic β cell glucotoxicity. Diabetes Metab Syndr Obes 8, 181–188, 2015.10.2147/DMSO.S82272439651725897251]Search in Google Scholar
[Wynes M, Riches D. Induction of macrophage insulin-like growth factor-1 expression by the Th2 cytokines IL-4 and IL-13. J Immunol 171, 3550–3559, 2003.10.4049/jimmunol.171.7.355014500651]Search in Google Scholar
[Yang K, Chi H. Metabolic control of Th17 cell generation and CNS inflammation. J Neurol Neurophysiol S12–004, 2014.10.4172/2155-9562.S12-004433438225705564]Search in Google Scholar
[Yazbeck R, Howarth GS, Abbott CA. Dipeptidyl peptidase inhibitors, an emerging drug class for inflammatory disease? Trends Pharmacol Sci 30, 600–607, 2009.10.1016/j.tips.2009.08.00319837468]Search in Google Scholar
[Yuan T, Zhao WG, Sun Q, Fu Y, Dong YY, Dong YX, Yang GH, Wang H. Association between four adipokines and insulin sensitivity in patients with obesity, type 1 or type 2 diabetes mellitus, and in the general Chinese population. Chin Med J (Engl) 123, 2018–2022, 2010.]Search in Google Scholar
[Zeng C, Shi X, Zhang B, Liu H, Zhang L, Ding W, Zhao Y. The imbalance of Th17/Th1/ Tregs in patients with type 2 diabetes: relationship with metabolic factors and complications. J Mol Med (Berl) 90, 175–186, 2012.10.1007/s00109-011-0816-521964948]Search in Google Scholar
[Zeng T, Zhang CL, Zhao XL, Xie KQ. Pentoxifylline for the treatment of nonalcoholic fatty liver disease: a meta-analysis of randomized double-blind, placebo-controlled studies. Eur J Gastroenterol Hepatol 26, 646–653, 2014.10.1097/MEG.000000000000006824743504]Search in Google Scholar
[Zherebiatiev A, Kamyshnyi A. Expression levels of proinflammatory cytokines and NLRP3 inflammasome in an experimental model of oxazolone-induced colitis. Iran J Allergy Asthma Immunol 15, 39–45, 2016.]Search in Google Scholar
[Zietek T, Daniel H. Intestinal nutrient sensing and blood glucose control. Curr Opin Clin Nutr Metab Care 18, 381–388, 2015.10.1097/MCO.000000000000018726001654]Search in Google Scholar